Alternatives to Ipsen

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.

A global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.

Clinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.

A global research-based biopharmaceutical company focused on developing advanced therapies for complex medical conditions.

Global biopharmaceutical company focused on oncology and neuroscience treatments.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotech company developing next-generation gene writing tools for advanced therapies.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.